Medical Updates

How Placenta Health May Influence Childhood ADHD Risk

Published on Oct 7, 2026
3 min read
How Placenta Health May Influence Childhood ADHD Risk - OC Academy Medical Insights
"A JAMA Psychiatry study links low third-trimester PlGF to child ADHD risk, highlighting the placenta-brain axis in early neurodevelopment."

Emerging clinical research indicates a profound connection between placental health and ADHD in pediatric cohorts. In fact, researchers from the University of Iowa recently identified an intriguing prenatal biomarker trajectory. Specifically, their work shows that compromised placental vascular function in late pregnancy elevates neurodevelopmental vulnerability. These findings emphasize that early brain development closely mirrors intrauterine vascular support.

Understanding Placental Health and ADHD Risk

The placenta performs essential physiological functions throughout gestation. For example, it supplies oxygen and critical nutrients to the developing fetus. Additionally, it eliminates metabolic waste and protects against environmental toxins. Despite these vital roles, scientists previously overlooked placental signaling in later psychiatric outcomes. However, recent evidence highlights an active placenta-brain axis during critical windows of neurogenesis. When placental tissue experiences vascular insufficiency, fetal brain maturation may suffer. Consequently, subtle disruptions in late gestation could trigger persistent neurodevelopmental changes.

Key Findings on Placental Growth Factor

In a cohort study published in JAMA Psychiatry, investigators evaluated 176 pregnancies. They specifically measured maternal serum levels of placental growth factor, or PlGF, across all trimesters. In typical pregnancies, PlGF concentrations rise sharply during the third trimester. However, pregnancies resulting in children with attention deficit hyperactivity disorder displayed a stunted trajectory. Notably, PlGF failed to demonstrate this normal third-trimester surge. Furthermore, each standard-deviation decline in late PlGF corresponded to significantly greater odds of an ADHD diagnosis. Interestingly, first-trimester and second-trimester PlGF levels showed no significant predictive association. Therefore, late gestational placental health appears uniquely tied to fetal neurodevelopmental pathways.

Clinical Implications for Maternal and Child Health

Maternal-fetal medicine specialists already utilize PlGF testing to assess complications such as preeclampsia. However, this study suggests broader clinical utility for placental biomarkers. Obstetricians in India and globally frequently manage gestational hypertension and fetal growth restriction. Consequently, understanding fetal origins of behavioral health provides clinicians with fresh prognostic insights. Moreover, early biomarker tracking might eventually support targeted developmental screenings during early childhood. Nevertheless, researchers caution against using PlGF as an immediate diagnostic tool for ADHD. Instead, these valuable observations warrant expanded longitudinal cohorts across diverse maternal populations.

Frequently Asked Questions

Q1: What is placental growth factor (PlGF) and why does it matter?

Placental growth factor is a key angiogenic protein produced by the placenta. It promotes vascular development and fetal nourishment. Furthermore, low maternal serum levels frequently indicate placental dysfunction or preeclampsia risk.

Q2: Does low PlGF during pregnancy directly cause ADHD?

No, low PlGF does not establish direct causation. Instead, the study reveals a significant statistical association between low third-trimester PlGF and subsequent childhood ADHD diagnoses.

Q3: Can doctors currently use PlGF tests to predict childhood ADHD?

Currently, clinicians cannot use PlGF to predict ADHD. Although PlGF serves as a reliable marker for preeclampsia, experts require larger prospective studies before considering neurodevelopmental screening applications.

References

  1. Placenta health could influence ADHD risk of child, study suggests - ETHealthworld
  2. Gumusoglu SB, Betz A, Storm A, Santillan DA, Santillan MK. Placental Growth Factor Trajectories During Pregnancy and Child ADHD. JAMA Psychiatry. Published online September 23, 2026. doi:10.1001/jamapsychiatry.2026.2336
  3. University of Iowa Carver College of Medicine Department of Obstetrics and Gynecology. Placenta problems associated with ADHD. Published September 30, 2026.

Related Articles You May Like